
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Controlling load-dependent kinetics of β-cardiac myosin at the single-molecule level
Chao Liu, Masataka Kawana, Dan Song, et al.
Nature Structural & Molecular Biology (2018) Vol. 25, Iss. 6, pp. 505-514
Open Access | Times Cited: 75
Chao Liu, Masataka Kawana, Dan Song, et al.
Nature Structural & Molecular Biology (2018) Vol. 25, Iss. 6, pp. 505-514
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
James A. Spudich
Pflügers Archiv - European Journal of Physiology (2019) Vol. 471, Iss. 5, pp. 701-717
Open Access | Times Cited: 156
James A. Spudich
Pflügers Archiv - European Journal of Physiology (2019) Vol. 471, Iss. 5, pp. 701-717
Open Access | Times Cited: 156
SETD3 is an actin histidine methyltransferase that prevents primary dystocia
Alex W. Wilkinson, Jonathan Diep, Shaobo Dai, et al.
Nature (2018) Vol. 565, Iss. 7739, pp. 372-376
Open Access | Times Cited: 139
Alex W. Wilkinson, Jonathan Diep, Shaobo Dai, et al.
Nature (2018) Vol. 565, Iss. 7739, pp. 372-376
Open Access | Times Cited: 139
Positive cardiac inotrope omecamtiv mecarbil activates muscle despite suppressing the myosin working stroke
Michael S. Woody, Michael J. Greenberg, Bipasha Barua, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Michael S. Woody, Michael J. Greenberg, Bipasha Barua, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Force Generation by Myosin Motors: A Structural Perspective
Julien Robert‐Paganin, Olena Pylypenko, Carlos Kikuti, et al.
Chemical Reviews (2019) Vol. 120, Iss. 1, pp. 5-35
Open Access | Times Cited: 120
Julien Robert‐Paganin, Olena Pylypenko, Carlos Kikuti, et al.
Chemical Reviews (2019) Vol. 120, Iss. 1, pp. 5-35
Open Access | Times Cited: 120
Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
Julien Robert‐Paganin, Daniel Auguin, Anne Houdusse
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Julien Robert‐Paganin, Daniel Auguin, Anne Houdusse
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 103
Single molecule mechanics resolves the earliest events in force generation by cardiac myosin
Michael S. Woody, Donald A. Winkelmann, Marco Capitanio, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 86
Michael S. Woody, Donald A. Winkelmann, Marco Capitanio, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 86
The hypertrophic cardiomyopathy mutations R403Q and R663H increase the number of myosin heads available to interact with actin
Saswata S. Sarkar, Darshan V. Trivedi, Makenna M. Morck, et al.
Science Advances (2020) Vol. 6, Iss. 14
Open Access | Times Cited: 86
Saswata S. Sarkar, Darshan V. Trivedi, Makenna M. Morck, et al.
Science Advances (2020) Vol. 6, Iss. 14
Open Access | Times Cited: 86
Cardiac myosin super relaxation (SRX): a perspective on fundamental biology, human disease and therapeutics
Manuel Schmid, Christopher N. Toepfer
Biology Open (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 65
Manuel Schmid, Christopher N. Toepfer
Biology Open (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 65
Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state
Alison Schroer Vander Roest, Chao Liu, Makenna M. Morck, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 24
Open Access | Times Cited: 62
Alison Schroer Vander Roest, Chao Liu, Makenna M. Morck, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 24
Open Access | Times Cited: 62
Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure
Sharlene M. Day, Jil C. Tardiff, E. Michael Ostap
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 53
Sharlene M. Day, Jil C. Tardiff, E. Michael Ostap
Journal of Clinical Investigation (2022) Vol. 132, Iss. 5
Open Access | Times Cited: 53
Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
Masataka Kawana, James A. Spudich, Kathleen M. Ruppel
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 39
Masataka Kawana, James A. Spudich, Kathleen M. Ruppel
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 39
Mavacamten, a precision medicine for hypertrophic cardiomyopathy: From a motor protein to patients
Suman Nag, Sampath K. Gollapudi, Carlos del Río, et al.
Science Advances (2023) Vol. 9, Iss. 30
Open Access | Times Cited: 37
Suman Nag, Sampath K. Gollapudi, Carlos del Río, et al.
Science Advances (2023) Vol. 9, Iss. 30
Open Access | Times Cited: 37
Modeling autoregulation of cardiac excitation-Ca-contraction and arrhythmogenic activities in response to mechanical load changes
Asuka Hatano, Leighton T. Izu, Ye Chen‐Izu, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111788-111788
Open Access | Times Cited: 1
Asuka Hatano, Leighton T. Izu, Ye Chen‐Izu, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111788-111788
Open Access | Times Cited: 1
Dilated cardiomyopathy myosin mutants have reduced force-generating capacity
Zoltán Ujfalusi, Carlos Vera, Srbolujub M. Mijailovich, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 23, pp. 9017-9029
Open Access | Times Cited: 68
Zoltán Ujfalusi, Carlos Vera, Srbolujub M. Mijailovich, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 23, pp. 9017-9029
Open Access | Times Cited: 68
The Myosin Family of Mechanoenzymes: From Mechanisms to Therapeutic Approaches
Darshan V. Trivedi, Suman Nag, Annamma Spudich, et al.
Annual Review of Biochemistry (2020) Vol. 89, Iss. 1, pp. 667-693
Open Access | Times Cited: 65
Darshan V. Trivedi, Suman Nag, Annamma Spudich, et al.
Annual Review of Biochemistry (2020) Vol. 89, Iss. 1, pp. 667-693
Open Access | Times Cited: 65
Cardiac myosin contraction and mechanotransduction in health and disease
Samantha K. Barrick, Michael J. Greenberg
Journal of Biological Chemistry (2021) Vol. 297, Iss. 5, pp. 101297-101297
Open Access | Times Cited: 54
Samantha K. Barrick, Michael J. Greenberg
Journal of Biological Chemistry (2021) Vol. 297, Iss. 5, pp. 101297-101297
Open Access | Times Cited: 54
Myosin with hypertrophic cardiac mutation R712L has a decreased working stroke which is rescued by omecamtiv mecarbil
Aaron Snoberger, Bipasha Barua, Jennifer L. Atherton, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 44
Aaron Snoberger, Bipasha Barua, Jennifer L. Atherton, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 44
Effects of mavacamten on Ca 2+ sensitivity of contraction as sarcomere length varied in human myocardium
Peter O. Awinda, Yemeserach Bishaw, Marissa Watanabe, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 24, pp. 5609-5621
Open Access | Times Cited: 46
Peter O. Awinda, Yemeserach Bishaw, Marissa Watanabe, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 24, pp. 5609-5621
Open Access | Times Cited: 46
Complexity in genetic cardiomyopathies and new approaches for mechanism-based precision medicine
Michael J. Greenberg, Jil C. Tardiff
The Journal of General Physiology (2021) Vol. 153, Iss. 3
Open Access | Times Cited: 36
Michael J. Greenberg, Jil C. Tardiff
The Journal of General Physiology (2021) Vol. 153, Iss. 3
Open Access | Times Cited: 36
Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties
Carlos Vera, Chloe A. Johnson, Jonathan Walklate, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 46, pp. 17451-17462
Open Access | Times Cited: 37
Carlos Vera, Chloe A. Johnson, Jonathan Walklate, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 46, pp. 17451-17462
Open Access | Times Cited: 37
Myocardial Contractility: Historical and Contemporary Considerations
William W. Muir, Robert L. Hamlin
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 36
William W. Muir, Robert L. Hamlin
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 36
Mechanistic insights into effects of the cardiac myosin activator omecamtiv mecarbil from mechanokinetic modelling
Alf Månsson
Frontiers in Physiology (2025) Vol. 16
Open Access
Alf Månsson
Frontiers in Physiology (2025) Vol. 16
Open Access
Hypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function
Makenna M. Morck, Debanjan Bhowmik, Divya Pathak, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 18
Makenna M. Morck, Debanjan Bhowmik, Divya Pathak, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 18
Principles and regulation of mechanosensing
Stefano Sala, Alexia Caillier, Patrick W. Oakes
Journal of Cell Science (2024) Vol. 137, Iss. 18
Closed Access | Times Cited: 3
Stefano Sala, Alexia Caillier, Patrick W. Oakes
Journal of Cell Science (2024) Vol. 137, Iss. 18
Closed Access | Times Cited: 3